| Literature DB >> 25965398 |
Ming Yang1, Ya-ru Yang1, Hui-jun Li1, Xue-song Lu2, Yong-mei Shi3, Bin Liu1, Hua-jun Chen1, Gao-jun Teng1, Rong Chen4, Edward H Herskovits4.
Abstract
Motor impairment after stroke is related to the integrity of the corticospinal tract (CST). However, considerable variability in motor impairment remains unexplained. To increase the accuracy in evaluating long-term motor function after ischemic stroke, we tested the hypothesis that combining diffusion tensor imaging (DTI) and gray matter (GM) volumetry can better characterize long-term motor deficit than either method alone in patients with chronic stroke. We recruited 31 patients whose Medical Research Council strength grade was ≤ 3/5 in the extensor muscles of the affected upper extremity in the acute phase. We used the Upper Extremity Fugl-Meyer (UE-FM) assessment to evaluate motor impairment, and as the primary outcome variable. We computed the fractional anisotropy ratio of the entire CST (CSTratio) and the volume of interest ratio (VOIratio), between ipsilesional and contralesional hemispheres, to explain long-term motor impairment. The results showed that CSTratio, VOIratio of motor-related brain regions, and VOIratio in the temporal lobe were correlated with UE-FM. A multiple regression model including CSTratio and VOIratio of the caudate nucleus explained 40.7% of the variability in UE-FM. The adjusted R2 of the regression model with CSTratio as an independent variable was 29.4%, and that of using VOIratio of the caudate nucleus as an independent variable was 23.1%. These results suggest that combining DTI and GM volumetry may achieve better explanation of long-term motor deficit in stroke patients, than using either measure individually. This finding may provide guidance in determining optimal neurorehabilitative interventions.Entities:
Mesh:
Year: 2015 PMID: 25965398 PMCID: PMC4428789 DOI: 10.1371/journal.pone.0125038
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical findings for 31 patients.
| Patient No. | Sex | Age | Education(years) | Lesion volume(mm3) | MRC | Lesion-side | UM-FM score | Time after stroke (months) | Lesion location |
|---|---|---|---|---|---|---|---|---|---|
| 01 | M | 67 | 9 | 551.2 | 0 | R | 25 | 9.7 | PLIC |
| 02 | F | 64 | 8 | 859.3 | 0 | L | 13 | 6.5 | CR, tempral lobe |
| 03 | M | 63 | 6 | 1914.0 | 3 | R | 4 | 23.3 | PLIC, parietal lobe |
| 04 | M | 37 | 17 | 1429.6 | 0 | R | 12 | 6.9 | PLIC, BG |
| 05 | M | 65 | 9 | 1339.0 | 0 | R | 15 | 54.4 | CR, BG |
| 06 | M | 60 | 9 | 5133.6 | 0 | R | 21 | 42.2 | CR, BG |
| 07 | F | 69 | 8 | 1280.8 | 3 | L | 6 | 12.6 | CR, BG |
| 08 | M | 62 | 6 | 392.0 | 3 | R | 31 | 15 | BS |
| 09 | M | 62 | 6 | 1592.6 | 0 | L | 5 | 26.2 | BG, CR |
| 10 | F | 73 | 0 | 845.0 | 1 | R | 8 | 40.4 | BG, CR |
| 11 | M | 59 | 15 | 11777.9 | 0 | L | 15 | 17.3 | CR, BG, temporal lobe |
| 12 | F | 50 | 1 | 830.7 | 3 | R | 10 | 6.3 | CR, BG |
| 13 | M | 60 | 8 | 575.1 | 3 | R | 26 | 58 | CR, BG |
| 14 | F | 65 | 0 | 15763.3 | 3 | R | 6 | 7.3 | CR, BG |
| 15 | F | 57 | 12 | 1287.5 | 2 | L | 38 | 40.2 | CR, BG |
| 16 | M | 54 | 9 | 144.0 | 3 | L | 43 | 11.9 | TH, BS |
| 17 | M | 68 | 3 | 84.9 | 3 | R | 44 | 14.4 | BS |
| 18 | M | 39 | 12 | 735.3 | 2 | L | 43 | 6.1 | BS |
| 19 | F | 78 | 15 | 1592.6 | 3 | L | 60 | 11.5 | PLIC, BG |
| 20 | M | 73 | 17 | 1098.6 | 3 | L | 64 | 107.4 | BG |
| 21 | F | 29 | 15 | 4701.6 | 1 | R | 61 | 14.1 | BG, CR |
| 22 | F | 62 | 8 | 123.0 | 2- | R | 64 | 7.4 | BS |
| 23 | M | 57 | 8 | 199.3 | 3 | R | 61 | 59.3 | BS |
| 24 | F | 80 | 19 | 620.8 | 3 | R | 63 | 11.9 | BG, CR |
| 25 | M | 56 | 12 | 832.6 | 3 | R | 62 | 8.2 | CR |
| 26 | F | 58 | 7 | 1181.6 | 3 | R | 62 | 7.6 | CR, BG |
| 27 | M | 61 | 0 | 96.3 | 3 | R | 66 | 12.7 | TH |
| 28 | F | 60 | 6 | 151.6 | 2 | R | 15 | 54.2 | BS |
| 29 | M | 70 | 14 | 775.3 | 3 | R | 47 | 7.9 | BS |
| 30 | M | 47 | 14 | 11921.9 | 3 | R | 17 | 10.4 | CR, BG, frontal lobe |
| 31 | M | 66 | 9 | 10230.1 | 3 | R | 9 | 7.2 | CR, BG, tempral lobe |
Note: M, male; F, female; L, left; R, right; UE-FM, Upper Extremity Fugl-Meyer assessment; MRC, Medical Research Council; IC, internal capsule; PLIC, posterior limb of IC; BG, basal ganglia; CR, corona radiata; TH, thalamus; CS, centrum semiovale
Fig 1Coronal views of individual color-coded FA map (a) and postprocessed CST map (b) of subject 03 in our study.
The patient’s UM-FM score was 25 and time after stroke was 9.7 months. The postprocessed CSTs map (the color of red-yellow in the Fig b) was overlayed with actual CSTs map (the blue color in the Fig a). The infarct (white color) is just inside the right CST and the volume of the ipsilesional CST decreased contrasted with the contralesional one. FAratio is 0.88. Colors indicate direction of fiber tracts (red, left–right; blue, cranio-caudal; green, anterior–posterior).
Relationships between demographic data, disease characteristics, and UE-FM assessment (n = 31).
| Variables |
|
| |
| Age, y | 60.4±11.2 | 0.02 | 0.93 |
| Chronicity, m | 23.2 ± 23.3 | 0.06 | 0.75 |
| Education, y | 9.1 ± 5.2 | 0.34 | 0.07 |
| Infarction volume, mm3
| 2582.8±4080.0 | -0.38 | 0.04 |
|
|
| ||
| Sex (male:female) | 19:12 | -0.20 | 0.84 |
| Side of lesion (L:R) | 9:22 | -0.14 | 0.89 |
* Data are means ± SD; UE-FM, Upper Extremity Fugl-Meyer assessment;
†correlation is significant at the 0.05 level.
Relationships between CST ratio, VOI ratio, and UE-FM (n = 31).
| Brain region | Ratio |
|
| Brain region | Ratio |
|
|
|---|---|---|---|---|---|---|---|
| CST | 0.92±0.06 | 0.56 | .001 | Cuneus | 0.94±0.11 | 0.13 | 0.48 |
| Precentral | 0.90±0.15 | 0.19 | 0.32 | Lingual | 1.0±0.10 | -0.03 | 0.88 |
| Frontal_Sup | 1.02±0.16 | 0.22 | 0.23 | Occipital_Sup | 1.01±0.11 | 0.15 | 0.41 |
| Frontal_Sup_Orb | 0.97±0.09 | 0.22 | 0.23 | Occipital_Mid | 0.89±0.38 | 0.05 | 0.80 |
| Frontal_Mid | 0.99±0.12 | 0.16 | 0.41 | Occipital_Inf | 1.02±0.15 | 0.19 | 0.30 |
| Frontal_Mid_Orb | 1.06±0.19 | -0.039 | 0.83 | Fusiform | 0.98±0.12 | 0.14 | 0.45 |
| Frontal_Inf_Oper | 1.08±0.30 | 0.17 | 0.38 | Postcentral | 0.91±0.11 | 0.26 | 0.16 |
| Frontal_Inf_Tri | 0.88±0.14 | 0.08 | 0.68 | Parietal_Sup | 0.95±0.19 | 0.29 | 0.11 |
| Frontal_Inf_Orb | 0.94±0.12 | 0.13 | 0.50 | Parietal_Inf | 0.87±0.58 | 0.07 | 0.72 |
| Rolandic_Oper | 1.03±0.24 | 0.31 | 0.09 | SupraMarginal | 1.26±0.46 | 0.06 | 0.76 |
| Supp_Motor_Area | 1.06±0.15 | 0.08 | 0.68 | Angular | 1.19±0.38 | 0.10 | 0.60 |
| Olfactory_L | 1.01±0.16 | 0.32 | 0.08 | Precuneus | 0.94±0.10 | 0.10 | 0.58 |
| Frontal_Sup_Medial | 0.89±0.28 | 0.007 | 0.97 | Paracentral_Lobule | 0.93±0.46 | 0.06 | 0.74 |
| Frontal_Med_Orb | 1.06±0.22 | -0.05 | 0.81 | Caudate | 0.84±0.30 | 0.51 | 0.004 |
| Rectus | 0.95±0.13 | -0.02 | 0.90 | Putamen | 1.06±0.33 | 0.18 | 0.33 |
| Insula | 0.86±0.21 | 0.29 | 0.11 | Pallidum | 0.97±0.07 | 0.13 | 0.49 |
| Cingulum_Ant | 0.97±0.09 | -0.001 | 1.0 | Thalamus | 0.96±0.20 | 0.54 | 0.002 |
| Cingulum_Mid | 1.02±0.13 | -0.04 | 0.83 | Heschl | 0.85±0.17 | 0.31 | 0.09 |
| Cingulum_Post | 0.90±0.57 | -0.09 | 0.62 | Temporal_Sup | 1.08±0.26 | 0.21 | 0.27 |
| Hippocampus | 0.95±0.11 | 0.25 | 0.17 | Temporal_Pole_ Sup | 0.92±0.18 | 0.39 | 0.03 |
| ParaHippocampal | 1.10±0.29 | 0.19 | 0.31 | Temporal_Mid | 0.93±0.06 | 0.46 | 0.01 |
| Amygdala | 0.97±0.13 | 0.28 | 0.13 | Temporal_Pole_Mid | 1.07±0.34 | 0.32 | 0.08 |
| Calcarine | 0.89±0.27 | 0.13 | 0.49 | Temporal_Inf | 1.03±0.13 | 0.25 | 0.17 |
CST: corticospinal tract; UE-FM, Upper Extremity Fugl-Meyer assessment;
*are enrolled independent variables (related to UE-FM, or motor-related AAL brain regions) in the multiple regression model;
†correlation is significant at the 0.05 level;
‡correlation is significant at the 0.01 level
Regression analysis of different independent variables.
| Model | Variable | Model Summary | ANOVA | Regression Coefficients | ||||
|---|---|---|---|---|---|---|---|---|
| R | Adjusted R | F | P Value | B Value | Beta | P Value | ||
| 1 | CST | 0.564 | 0.294 | 13.500 | 0.001 | 201.901 | 0.564 | 0.001 |
| 2 | Caudate | 0.507 | 0.231 | 10.029 | 0.004 | 38.351 | 0.507 | 0.004 |
| 3 | Thalamus | 0.544 | 0.271 | 12.178 | 0.002 | 60.800 | 0.544 | 0.002 |
| 4 | CST + | 0.644 | 0.373 | 9.908 | 0.001 | 140.800 | 0.393 | 0.024 |
| Thalamus | 39.670 | 0.355 | 0.040 | |||||
|
| CST + | 0.668 | 0.407 | 11.289 | 0.000 | 162.923 | 0.455 | 0.004 |
| Caudate | 28.366 | 0.375 | 0.016 | |||||
UE-FM, Upper Extremity Fugl-Meyer assessment; ANOVA, analysis of variance; CST: corticospinal tract;
1, CSTratio;
2, VOI ratio of caudate;
3, VOI ratio of all structures which were significantly correlated with UE-FM and motor-related AAL regions;
4, CSTratio and VOIratio of thalamus;
5, all variables from lesion volume, DTI and GM volumetry;
*selected model.